3 unstoppable ASX 200 shares to buy and hold forever

These shares have smashed the market and look well-placed to continue this trend.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the best ways to build your wealth is by investing in ASX 200 shares that can grow strongly over long periods.

But not all shares are capable of doing this. So, let's take a look at three unstoppable shares that have incredible track records and positive long-term growth outlooks.

They are as follows:

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.

Image source: Getty Images

REA Group Ltd (ASX: REA)

REA Group is an unstoppable ASX 200 share that has made investors rich. Over the past 15 years, the realestate.com.au operator's shares have delivered an average total return of 20.8% per annum.

Its property platforms are embedded in how Australians buy and sell homes. That network effect has been built over decades and is incredibly difficult to replicate.

What drives REA's compounding is not just property market activity, but its ability to increase revenue per customer. Premium listings, data tools, and value-added services allow the company to grow even when transaction volumes are not booming.

Given its domination of the local market and its growing Indian business, the future looks bright for this ASX share.

ResMed Inc. (ASX: RMD)

Another ASX 200 share that has delivered strong returns for investors is ResMed. It has achieved an average total return of 16.95% per annum since 2016.

This medical device company operates in sleep apnoea and respiratory care, which are areas driven by long-term health trends rather than discretionary spending. Diagnosis rates continue to rise, and once patients are on therapy, they tend to stay there.

What makes ResMed particularly effective at compounding is how it blends hardware with software and data. Devices, masks, cloud platforms, and analytics all work together to create recurring revenue and long-term customer relationships.

Management estimates that the total addressable market for sleep apnoea is over 1 billion people. This gives ResMed a significant growth runway for the next decade and beyond.

TechnologyOne Ltd (ASX: TNE)

Finally, TechnologyOne is a classic example of quiet compounding. Over the past decade, this ASX 200 share has delivered an average total return of 20.2% per annum.

The company provides mission-critical software to governments, universities, and large organisations. These customers do not switch systems lightly, which gives TechnologyOne a sticky client base and highly predictable revenue.

In addition, its shift to a software-as-a-service model has been highly successful and fundamentally changed the business. Revenue visibility has improved, cash generation has strengthened, and recurring income has become a much larger part of the mix.

And with management confident that it can double in size every five years, this ASX share could be destined to outperform long into the future.

Motley Fool contributor James Mickleboro has positions in REA Group, ResMed, and Technology One. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed and Technology One. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Business people discussing project on digital tablet.
Growth Shares

Where to invest $20,000 in ASX 200 shares in June

Wondering where to invest? Here are three shares that analysts rate as buys.

Read more »

A woman is excited as she reads the latest rumour on her phone.
Growth Shares

Brokers rate these 6 ASX 200 shares a strong buy, and tip upsides of up to 227%

It looks like these ASX 200 shares could drag the index higher over the next 12 months.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Growth Shares

3 incredible ASX growth shares tipped to rise 20% to 70%

Brokers are tipping these shares to rise strongly from current levels.

Read more »

a man sits on a ridge high above a large city full of high rise buildings as though he is thinking, contemplating the vista below.
Growth Shares

2 top ASX shares to buy and hold for the next decade

These two investments look like excellent long-term buys today!

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Growth Shares

2 incredible ASX 200 shares to buy and hold for 10 years

These shares could help you build wealth over the long term.

Read more »

Excited couple celebrating success while looking at smartphone.
Growth Shares

3 buy-rated ASX growth shares tipped to rise 30%+

Analysts are bullish on these names. Here's what you need to know.

Read more »

Piggy bank rocketing.
Growth Shares

SpaceX starts trading today. Here's what ASX investors need to know

Here's how ASX investors can gain exposure.

Read more »

A young man looks like he his thinking holding his hand to his chin and gazing off to the side amid a backdrop of hand drawn lightbulbs that are lit up on a chalkboard.
Growth Shares

Where to invest $50,000 in ASX 200 shares in FY27

These shares could be worth considering ahead of the new financial why. Let's look at the reasons why.

Read more »